A detailed history of Lazard Asset Management LLC transactions in Orasure Technologies Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 124,431 shares of OSUR stock, worth $452,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares
124,431
Previous 36,562 240.33%
Holding current value
$452,928
Previous $155,000 242.58%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.93 - $4.59 $345,325 - $403,318
87,869 Added 240.33%
124,431 $531,000
Q2 2024

Aug 14, 2024

SELL
$4.2 - $6.18 $85,453 - $125,738
-20,346 Reduced 35.75%
36,562 $155,000
Q1 2024

May 14, 2024

BUY
$6.08 - $8.28 $39,520 - $53,819
6,500 Added 12.89%
56,908 $349,000
Q4 2023

Feb 14, 2024

BUY
$5.13 - $8.35 $67,161 - $109,318
13,092 Added 35.08%
50,408 $413,000
Q3 2023

Nov 14, 2023

BUY
$4.4 - $6.91 $49,434 - $77,633
11,235 Added 43.08%
37,316 $221,000
Q2 2023

Aug 14, 2023

BUY
$4.88 - $7.39 $127,275 - $192,738
26,081 New
26,081 $130,000
Q1 2022

May 13, 2022

SELL
$6.62 - $9.33 $12,995 - $18,314
-1,963 Reduced 25.37%
5,774 $39,000
Q4 2021

Feb 09, 2022

BUY
$8.3 - $11.29 $27,058 - $36,805
3,260 Added 72.82%
7,737 $67,000
Q3 2021

Nov 15, 2021

SELL
$9.73 - $13.38 $3,327 - $4,575
-342 Reduced 7.1%
4,477 $50,000
Q2 2021

Aug 12, 2021

BUY
$9.02 - $11.68 $43,467 - $56,285
4,819 New
4,819 $48,000
Q1 2020

May 14, 2020

SELL
$5.57 - $10.76 $12,003 - $23,187
-2,155 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$7.21 - $8.89 $8,190 - $10,099
1,136 Added 111.48%
2,155 $17,000
Q3 2019

Nov 14, 2019

BUY
$6.57 - $9.46 $6,694 - $9,639
1,019 New
1,019 $7,000

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $264M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.